|
Volume
1 Number 5
May 2013
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Research
>
Volume
1, Year 2013
>
Number 5, May
|
|
>>> ISSUE IN PREPARATION <<<
|
CONTENTS
|
▼
|
|
CASE
REPORTS
CLASSIFICATION
DIAGNOSIS
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
FOLLOW-UP,
QUALITY OF LIFE
INTEGRATIVE
MEDICINE
OVERALL
MANAGEMENT
PROGNOSIS
TREATMENT
|
|
|
CASE
REPORTS
|
▲
|
|
|
|
|
CLASSIFICATION
|
▲
|
|
|
|
|
DIAGNOSIS
|
▲
|
|
|
|
|
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
|
▲
|
|
|
|
|
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
|
▲
|
.
|
Klink
JC, Bañez LL, Gerber L, Lark A, Vollmer RT, Freedland SJ.
Intratumoral
inflammation is associated with more aggressive prostate cancer.
World
J Urol. 2013 Dec;31(6):1497-503. doi: 10.1007/s00345-013-1065-8.
Epub 2013 Apr 2.
Source
| Full
text |
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Ellison
JS, He C, Wood DP.
Early
Post-Operative Urinary and Sexual Function Predicts Functional
Recovery at One Year Following Prostatectomy.
J
Urol. 2013 Apr 19. doi:pii: S0022-5347(13)04095-0.
10.1016/j.juro.2013.04.045. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Jakobsson
L, Persson L, Lundqvist P.
Daily
life and life quality 3 years following prostate cancer treatment.
BMC
Nurs. 2013 Apr 10;12:11. doi: 10.1186/1472-6955-12-11.
Source
| Full
text |
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
.
|
Bassett
JK, Severi G, Hodge AM, Macinnis RJ, Gibson RA, Hopper JL, English
DR, Giles GG.
Plasma
phospholipid fatty acids, dietary fatty acids and prostate cancer
risk.
Int
J Cancer. 2013 Apr 11. doi: 10.1002/ijc.28203. [Epub ahead of
print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Chao C, Jacobsen SJ, Xu
L, Wallner LP, Porter KR, Williams SG.
Use of statins and
prostate cancer recurrence among patients treated with radical
prostatectomy.
BJU Int. 2013 May;111(6):954-62. doi:
10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Hagen
RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR.
Epigallocatechin-3-gallate
promotes apoptosis and expression of the caspase 9a splice variant
in PC3 prostate cancer cells.
Int
J Oncol. 2013 Jul;43(1):194-200. doi: 10.3892/ijo.2013.1920. Epub
2013 Apr 24.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Kirby M.
Use
of statins and prostate cancer recurrence among patients treated
with radical prostatectomy.
BJU
Int. 2013 May;111(6):854-6. doi: 10.1111/j.1464-410X.2012.11722.x.
First published: 25 April 2013
Editorial.
Refers to: Chao C et al, Use of statins and prostate cancer
recurrence among patients treated with radical prostatectomy. BJU
Int. 2013 May;111(6):954-62. doi:
10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|
OVERALL
MANAGEMENT
|
▲
|
|
|
|
|
PROGNOSIS
|
▲
|
.
|
Rapiti
E, Schaffar R, Iselin C, Miralbell R, Pelte MF, Weber D, Zanetti
R, Neyroud-Caspar I, Bouchardy C
Importance
and determinants of Gleason score undergrading on biopsy sample of
prostate cancer in a population-based study.
BMC
Urol. 2013 Apr 11;13:19. doi: 10.1186/1471-2490-13-19.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Yoshida T, Nakayama M, Matsuzaki K, Kobayashi Y, Takeda K, Arai Y,
Kakimoto K, Nishimura K.
Validation of the Prostate
Cancer Risk Index (PRIX): a simple scoring system to predict risk
of biochemical relapse after radical prostatectomy for prostate
cancer.
Jpn J Clin Oncol. 2011 Nov;41(11):1271-6. doi:
10.1093/jjco/hyr139. Epub 2011 Oct 4.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Yoshioka Y, Inoue T.
Prostate Risk Index (PRIX) as a new
method of risk classification for clinically localized prostate
cancer.
Strahlenther Onkol. 2007 Sep;183(9):490-6. DOI
https://doi.org/10.1007/s00066-007-1692-3
Source
| Full
text |
Similar
articles
|
|
|
TREATMENT
|
▲
|
|
|
|
|
|
|
|
|
bottom
|
▲
|
|
|
.
|
Source |
Full text |
|
